Plaque erosion risk and JAK2 V617F variant

被引:0
|
作者
Wang, Shengfang [1 ,2 ,3 ]
Luo, Xing [1 ,3 ]
Hu, Sining [1 ,3 ]
Zhao, Chen [1 ,3 ]
Sun, Qianhui [1 ,3 ]
Zeng, Ming [1 ,3 ]
Bao, Xiaoyi [1 ,3 ]
Wang, Yini [1 ,3 ]
Wu, Fangfang [4 ]
Yang, Yeqiu [1 ,3 ]
Lv, Ying [1 ,3 ]
Bai, Xiaoxuan [1 ,3 ]
Hao, Wei [1 ,3 ]
Liu, Minghao [1 ,3 ]
Yi, Boling [1 ,3 ]
Chen, Yuwu [1 ,3 ]
Meng, Wei [1 ,3 ]
Li, Ji [1 ,3 ]
Li, Man [1 ,3 ]
Huang, Jianxin [1 ,3 ]
Wu, Tianyu [1 ,3 ]
Zhao, Yipin [2 ]
Zhang, Zhulin [5 ]
An, Jian [6 ]
Libby, Peter [7 ]
Jia, Haibo [1 ,3 ]
Yu, Bo [1 ,3 ]
机构
[1] Harbin Med Univ, Coll Pharm,Affiliated Hosp 2, Dept Pharmacol, State Key Lab Frigid Zone Cardiovasc Dis SKLFZCD, 246 Xuefu Rd, Harbin 150000, Peoples R China
[2] Zhengzhou Univ, Cent China Fuwai Hosp, Henan Prov Peoples Hosp Heart Ctr, Dept Cardiol, 1 Fuwai Ave, Zhengzhou 451464, Henan, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Peoples R China
[4] Northeast Agr Univ, Coll Arts & Sci, 600 Changjiang Rd, Harbin 150030, Peoples R China
[5] Shanxi Cardiovasc Hosp, Dept Cardiol, 18 Yifen St, Taiyuan, Peoples R China
[6] Northeast Agr Univ, Coll Engn, 101 Xuefu St, Harbin 150030, Peoples R China
[7] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Div Cardiovasc Med, Boston, MA USA
基金
中国国家自然科学基金;
关键词
Clonal haematopoiesis; Myocardial infarction; JAK2; V617F; Plaque erosion; Neutrophil; VIMENTIN INTERMEDIATE-FILAMENTS; ACUTE CORONARY SYNDROMES; CLONAL HEMATOPOIESIS; NEUTROPHIL RECRUITMENT; EXTRACELLULAR-MATRIX; HEART-FAILURE; HYALURONAN; ATHEROSCLEROSIS; INFLAMMATION; MECHANISMS;
D O I
10.1093/eurheartj/ehaf114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aims Clonal haematopoiesis of indeterminate potential (CHIP) can increase the risk of myocardial infarction (MI). Among various CHIP mutations, JAK2 V617F substantially elevated this risk. However, the specific associations between JAK2 V617F and two mechanisms of MI, plaque erosion and plaque rupture, remain unclear. Methods Case-control studies investigated these associations. A total of 728 erosion cases, 919 rupture cases, and 804 controls were included from our centre. Digital-drop polymerase chain reaction was performed on these individuals to identify the presence of JAK2 V617F. Previous experimental work has implicated neutrophils in the pathogenesis of erosion in the presence of this mutation. Thus, single-cell RNA sequencing of neutrophils from both JAK2 V617F carriers and healthy donors was performed to seek the potential mechanisms responsible for erosion associated with JAK2 V617F. Results Among the participants, 26 (3.57%) erosion patients, 7 (.76%) rupture patients, and 3 (.37%) controls were identified as JAK2 V617F carriers with a variant allele frequency (VAF) >= 1%. The carriers among the erosion patients exhibited higher platelet counts and lower glycated haemoglobin and blood lipid levels. Logistic regression analysis, considering erosion or rupture as separate cases, revealed that JAK2 V617F carriers with a VAF >= 1% showed a significant association with erosion [odds ratio (OR) 16.246, 95% confidence interval (CI) 4.624-57.080, P < .0001], but not with rupture (OR 1.677, 95% CI .379-7.415, P = .495). Single-cell RNA-sequencing data indicated that neutrophils from JAK2 V617F carriers displayed augmented expression levels of genes and gene sets associated with activation, adhesion, migration, and granule secretion. Conclusions JAK2 V617F linked to a high risk of erosion, an association to which enhanced neutrophil activation may contribute.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] No evidence for amplification of V617F JAK2 in myeloproliferative disorders
    A V Jones
    D J Bunyan
    N C P Cross
    Leukemia, 2007, 21 : 2561 - 2563
  • [32] The prevalence of JAK2 V617F mutation in myelodysplastic syndrome
    Antolic, M. Radic
    Zadro, R.
    Roncevic, P.
    Kinda, S. Basic
    Labar, B.
    BLOOD REVIEWS, 2007, 21 : S126 - S126
  • [33] Absence of JAK2 V617F mutation in gastric cancers
    Lee, JW
    Soung, YH
    Kim, SY
    Nam, SW
    Park, WS
    Lee, JY
    Yoo, NJ
    Lee, SH
    ACTA ONCOLOGICA, 2006, 45 (02) : 222 - 223
  • [34] JAK2 V617F: implications for thrombosis in myeloproliferative diseases
    Hexner, Elizabeth O.
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (05) : 450 - 454
  • [35] The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
    Nielsen, Camilla
    Birgens, Henrik S.
    Nordestgaard, Borge G.
    Kjaer, Lasse
    Bojesen, Stig E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 450 - 453
  • [36] Cerebral venous thrombosis risk factors and incidence of JAK2 V617F mutation
    Kostal, M.
    Dulicek, P.
    Maly, J.
    Krajickova, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 804 - 804
  • [37] Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells
    Cheng, Zhiyong
    Fu, Jianzhu
    Liu, Guimin
    Zhang, Lijun
    Xu, Qian
    Wang, Su-yun
    LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 196 - 203
  • [38] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [39] International external quality assurance of JAK2 V617F quantification
    Asp, Julia
    Skov, Vibe
    Bellosillo, Beatriz
    Kristensen, Thomas
    Lippert, Eric
    Dicker, Frank
    Schwarz, Jiri
    Wojtaszewska, Marzena
    Palmqvist, Lars
    Akiki, Susanna
    Aggerholm, Anni
    Andersen, Morten Tolstrup
    Girodon, Francois
    Kjaer, Lasse
    Leibundgut, Elisabeth Oppliger
    Pancrazzi, Alessandro
    Vorland, Marta
    Andrikovics, Hajnalka
    Kralovics, Robert
    Cassinat, Bruno
    Coucelo, Margarida
    Eftimov, Aleksandar
    Haslam, Karl
    Kusec, Rajko
    Link-Lenczowska, Dorota
    Lode, Laurence
    Matiakowska, Karolina
    Naguib, Dina
    Navaglia, Filippo
    Novotny, Guy Wayne
    Percy, Melanie J.
    Sudarikov, Andrey
    Hermouet, Sylvie
    Pallisgaard, Niels
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1111 - 1118
  • [40] JAK2 V617F MUTATION SCANNING IN PATIENTS WITH ADRENAL INCIDENTALOMA
    Ekinci, F.
    Soyaltin, U. E.
    Kutbay, Y. B.
    Yasar, H. Y.
    Yildirim, T. Demirci
    Akar, H.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 150 - 153